Nektar Therapeutics (NKTR) to Release Earnings on Thursday

Chronological Source Flow
Back

AI Fusion Summary

Nektar Therapeutics is scheduled to announce its Q4 2025 earnings after the market closes on Thursday, March 12th. Analysts are forecasting a loss of $2.69 per share and revenue of $10.439 million for the quarter.
#Nektar Therapeutics #NKTR #earnings report #Q4 2025 #earnings per share #revenue #biopharmaceutical #stock market
05/03 08:18 defenseworld.net
3 Πηγές

Nektar Therapeutics (NKTR) to Release Earnings on Thursday

05/03 08:54 defenseworld.net

Cartesian Therapeutics (RNAC) to Release Earnings on Thursday

05/03 09:32 defenseworld.net

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $38.50 Average Price Target from Brokerages

Comments
Loading...
0